Results 61 to 70 of about 2,572,587 (193)

[Continuous subcutaneous insulin infusion].

Acta medica portuguesa, 2012
Continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) represent two strategies of intensive insulin therapy, obtaining a strict metabolic control. The importance of such rigorous metabolic control in reducing the frequency and severity of diabetes long-term complications was highlighted by the Diabetes Control and ...
Ana Margarida, Balsa, Celestino, Neves, Marta, Alves, Miguel, Pereira, Davide, Carvalho, J Luís, Medina   +5 more
openaire   +1 more source

Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. [PDF]

, 2007
peer reviewedThe purification of animal insulin preparations and the use of human recombinant insulin have markedly reduced the incidence but not completely suppressed the occurrence of insulin allergy manifestations.
Scheen, André, Radermecker, Régis
core   +1 more source

Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma

Clinical Diabetes and Endocrinology, 2018
Background Ectopic insulin-like growth factor (IGF)-2 production is a rare complication of an array of epithelial and mesenchymal tumors, and can clinically manifest as life-threatening hypoglycemia.
Eric D. Buras, Emily Weatherup, Jennifer Wyckoff   +2 more
doaj   +1 more source

Insulin/carbohydrates ratio during the first 6‐month therapy with insulin degludec in a paediatric population with type 1 diabetes previously treated with insulin glargine. An observational longitudinal study

Endocrinology, Diabetes & Metabolism, 2020
Background No data exist about the changes induced by the transition from first‐generation long‐acting insulins to second‐generation long‐acting analogues in the paediatric population.
Stefano Tumini, Olimpia Iacono, Laura Comegna, Elisabetta Fioretti, Paola Guidone, Gabriella Levantini, Daniele Panichi, Milena Catenaro, Ilaria Rossi, Flavia Amaro, Giusi Graziano, Maria Chiara Rossi, Paola Cipriano   +12 more
doaj   +1 more source

Comparison of Metabolic Effects of Continuous Subcutaneous Insulin Infusion Treatment with Conventional Insulin Treatment in Type l Diabetes Mellitus

Endocrinology Research and Practice, 2022
We evaluated the feasibility and effectiveness of the continuous subcutaneous insulin infusion (CSN) therapy as compared to conventional injection treatment (CIT) in a diabetes clinic in a one month randomized study of 42 type l diabetic patients. During
Ercan Tuncel, Şazi İmamoğlu, R. Ali, F. Özkalemkaş, Erdinç Ertürk, Ayhan Arınık   +5 more
doaj   +2 more sources

Management of Severe Congenital Protein C Deficiency with Continuous Subcutaneous Infusion via Insulin Pump: A Pediatric Case Report

Children
Severe congenital Protein C deficiency (SCPCD) is a rare autosomal recessive thrombophilia that typically presents in the neonatal period with early-onset life-threatening thrombotic complications.
Angelo Gentile, Giordano Spacco, Nicola Minuto, Vera Morsellino, Sandro Dallorso, Angelo Claudio Molinari, Mohamad Maghnie, Marta Bassi, Laura Banov   +8 more
doaj   +1 more source

Continuous infusion of subcutaneous compared to intravenous insulin for tight glycaemic control in medical intensive care unit patients

, 2008
The aim of this randomised controlled study was to compare continuous subcutaneous insulin infusion using an insulin pump with the traditional continuous intravenous infusion method for tight glycaemic control.
Bodur, H. A., Saygili, F., Saygili, S., Doganay, L. H., Yesil, S.   +4 more
core   +1 more source

Issue of Adjustment to Continuous Subcutaneous Insulin Infusion Devices [PDF]

, 2014
Introduction: Continuous subcutaneous insulin infusion with an insulin pump provides best practice for prevention of tertiary complications of insulin-dependent diabetes.
Piven, Emily F., Bader, Julia, Nazeran, Homer, Lovett, Ursel, Julia Bader, Homer Nazeran, Emily Piven, Ursel Lovett   +7 more
core   +1 more source

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

, 2002
Objective To compare glycaemic control and insulin dosage in people with type 1 diabetes treated by continuous subcutaneous insulin infusion (insulin infusion pump therapy) or optimised insulin injections. Design Meta-analysis of 12 randomised controlled
Kerry, S, Mattock, M, Pickup, J
core   +1 more source

Use of U-500 insulin in continuous subcutaneous insulin infusion in a patient with severe insulin resistance

, 2010
U-500 insulin (Humulin R; Eli Lilly, Indianapolis, Indiana, USA) is five times as concentrated as conventional U-100 insulins. We report the case of a woman with marked insulin resistance in whom the use of U-500 insulin in continuous subcutaneous ...
Devesh Sennik, Safdar Naqvi, Helen Ward
core   +1 more source